AVITA Medical Inc.

NASDAQ: RCEL · Real-Time Price · USD
6.29
-0.11 (-1.72%)
At close: May 23, 2025, 3:59 PM
6.59
4.77%
After-hours: May 23, 2025, 04:43 PM EDT

AVITA Medical Statistics

Share Statistics

AVITA Medical has 26.43M shares outstanding. The number of shares has increased by 2.16% in one year.

Shares Outstanding 26.43M
Shares Change (YoY) 2.16%
Shares Change (QoQ) 0.53%
Owned by Institutions (%) 25.36%
Shares Floating n/a
Failed to Deliver (FTD) Shares 4,122
FTD / Avg. Volume 1.78%

Short Selling Information

The latest short interest is 2.97M, so 11.25% of the outstanding shares have been sold short.

Short Interest 2.97M
Short % of Shares Out 11.25%
Short % of Float 11.34%
Short Ratio (days to cover) 23.92

Valuation Ratios

The PE ratio is -5.36 and the forward PE ratio is -9.62. AVITA Medical's PEG ratio is -0.08.

PE Ratio -5.36
Forward PE -9.62
PS Ratio 5.16
Forward PS 0.3
PB Ratio 73.64
P/FCF Ratio -5.69
PEG Ratio -0.08
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for AVITA Medical.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.83, with a Debt / Equity ratio of 10.22.

Current Ratio 2.83
Quick Ratio 2.47
Debt / Equity 10.22
Debt / EBITDA -0.83
Debt / FCF -0.79
Interest Coverage -10.56

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $247,119.23
Profits Per Employee $-237,865.38
Employee Count 260
Asset Turnover 0.81
Inventory Turnover 1.25

Taxes

Income Tax 54K
Effective Tax Rate -0.09%

Stock Price Statistics

The stock price has increased by -21.9% in the last 52 weeks. The beta is 1.74, so AVITA Medical's price volatility has been higher than the market average.

Beta 1.74
52-Week Price Change -21.9%
50-Day Moving Average 8.54
200-Day Moving Average 9.98
Relative Strength Index (RSI) 29.83
Average Volume (20 Days) 232,222

Income Statement

In the last 12 months, AVITA Medical had revenue of 64.25M and earned -61.84M in profits. Earnings per share was -2.39.

Revenue 64.25M
Gross Profit 55.16M
Operating Income -56.59M
Net Income -61.84M
EBITDA -55.34M
EBIT -56.43M
Earnings Per Share (EPS) -2.39
Full Income Statement

Balance Sheet

The company has 14.05M in cash and 45.98M in debt, giving a net cash position of -31.93M.

Cash & Cash Equivalents 14.05M
Total Debt 45.98M
Net Cash -31.93M
Retained Earnings -359.81M
Total Assets 79.71M
Working Capital 36.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -48.94M and capital expenditures -9.33M, giving a free cash flow of -58.27M.

Operating Cash Flow -48.94M
Capital Expenditures -9.33M
Free Cash Flow -58.27M
FCF Per Share -2.25
Full Cash Flow Statement

Margins

Gross margin is 85.85%, with operating and profit margins of -88.08% and -96.26%.

Gross Margin 85.85%
Operating Margin -88.08%
Pretax Margin -96.17%
Profit Margin -96.26%
EBITDA Margin -86.13%
EBIT Margin -88.08%
FCF Margin -90.69%

Dividends & Yields

RCEL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for RCEL is $17.5, which is 172.6% higher than the current price. The consensus rating is "Buy".

Price Target $17.5
Price Target Difference 172.6%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Stock Splits

The last stock split was on Jun 30, 2020. It was a backward split with a ratio of 1:5.

Last Split Date Jun 30, 2020
Split Type backward
Split Ratio 1:5

Scores

Altman Z-Score -5.95
Piotroski F-Score 3